Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients
Phase 4
- Conditions
- Opiate Withdrawal SyndromeChronic Pain
- Interventions
- Other: Sham acupunctureOther: NADA acupuncture
- Registration Number
- NCT03397212
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
This project aims at examining the following hypotheses:
* Treatment with NADA and clonidine reduces intensity of withdrawal symptoms to a greater extent than treatment with clonidine.
* Opioid withdrawal improves pain, physical and mental functioning and reduces opioid consumption 3 months and 1 year after withdrawal.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Chronic pain patients treated with opioids over 3 months
- The patient's doctor or nurse assesses that there is an indication to opioid withdrawal and / or the patient wishes to withdraw.
- The patient is motivated for opioid withdrawal
- The patient has experienced withdrawal symptoms
- The patient must be able to understand, speak and write Danish
- The patient must be able to transport himself to the pain center
Exclusion Criteria
- Children under 18 years old
- External ear infection
- Treatment with benzodiazepines.
- Active substance abuse and alcohol abuse.
- Contraindications for treatment with clonidine:
- Allergy
- Bradyarrhythmias caused by diseased sinus cube or AV block of 2nd or 3rd grade.
- lactose intolerance
- Heart failure
- High medullary damage
- Cardiac conduction disturbances
- Pregnancy and breastfeeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Sham acupuncture and Clonidine Sham acupuncture Sham ear acupuncture and treatment with tbl Clonidine NADA and Clonidine NADA acupuncture NADA acupuncture and treatment with tbl Clonidine
- Primary Outcome Measures
Name Time Method Change in intensity of withdrawal symptoms 3 months and 1 year Change in intensity of withdrawal symptoms assessed with Danish withdrawal symptom questionnaire
- Secondary Outcome Measures
Name Time Method Change in quality of life assessed with SF36 3 months and 1 year Change in quality of life assessed with SF36
Trial Locations
- Locations (1)
Rigshospitalet
🇩🇰Copenhagen, Denmark